p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab.

Autor: Fukuoka, Shota1 (AUTHOR), Koga, Yoshikatsu2 (AUTHOR), Yamauchi, Mayumi3 (AUTHOR), Koganemaru, Shigehiro4 (AUTHOR), Yasunaga, Masahiro2 (AUTHOR), Shitara, Kohei3 (AUTHOR), Doi, Toshihiko1,4 (AUTHOR), Yoshino, Takayuki3 (AUTHOR), Kuronita, Toshio5 (AUTHOR), Elenbaas, Brian6 (AUTHOR), Wahra, Pamela6 (AUTHOR), Zhang, Hong6 (AUTHOR), Crowley, Lindsey6 (AUTHOR), Jenkins, Molly H.6 (AUTHOR), Clark, Anderson6 (AUTHOR), Kojima, Takashi3 (AUTHOR) takojima@east.ncc.go.jp
Zdroj: Scientific Reports. 11/18/2023, Vol. 13 Issue 1, p1-17. 17p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje